Cargando…
KCND2: A prognostic biomarker and regulator of immune function in gastric cancer
BACKGROUND: Gastric cancer is a highly heterogeneous disease, which makes it challenging to develop effective targeted therapies. Although the potassium voltage‐gated channel subfamily D (KCND) channels, particularly KCND2 (also known as Kv4.2), have found evidence of involvement in the occurrence a...
Autores principales: | Zhou, Hongying, Su, Dan, Chen, Yun, Zhang, Yiwen, Huang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469724/ https://www.ncbi.nlm.nih.gov/pubmed/37347147 http://dx.doi.org/10.1002/cam4.6236 |
Ejemplares similares
-
Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22
por: Li, Mengjie, et al.
Publicado: (2022) -
Association of Cardiac Electrical Disorders With KCND3 Gene Mutation
por: Ahammed, Md Ripon, et al.
Publicado: (2023) -
A novel KCND3 mutation associated with early-onset lone atrial fibrillation
por: Huang, Yuan, et al.
Publicado: (2017) -
KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes
por: Pollini, Luca, et al.
Publicado: (2020) -
A Novel KCND3 Variant in a Korean Family With SCA19
por: Ha, Hongmin, et al.
Publicado: (2022)